Switch to:
Synageva BioPharma Corp (NAS:GEVA)
Gross Profit
\$5.83 Mil (TTM As of Mar. 2015)

Synageva BioPharma Corp's gross profit for the three months ended in Mar. 2015 was \$0.93 Mil. Synageva BioPharma Corp's gross profit for the trailing twelve months (TTM) ended in Mar. 2015 was \$5.83 Mil.

Gross Margin is calculated as gross profit divided by its revenue. Synageva BioPharma Corp's gross profit for the three months ended in Mar. 2015 was \$0.93 Mil. Synageva BioPharma Corp's revenue for the three months ended in Mar. 2015 was \$0.93 Mil. Therefore, Synageva BioPharma Corp's Gross Margin for the quarter that ended in Mar. 2015 was 100.00%.

Synageva BioPharma Corp had a gross margin of 100.00% for the quarter that ended in Mar. 2015 => Durable competitive advantage

Definition

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Synageva BioPharma Corp's Gross Profit for the fiscal year that ended in Dec. 2014 is calculated as

 Gross Profit (A: Dec. 2014 ) = Revenue - Cost of Goods Sold = 6.492 - 0 = 6.49

Synageva BioPharma Corp's Gross Profit for the quarter that ended in Mar. 2015 is calculated as

 Gross Profit (Q: Mar. 2015 ) = Revenue - Cost of Goods Sold = 0.927 - 0 = 0.93

Synageva BioPharma Corp Gross Profit for the trailing twelve months (TTM) ended in Mar. 2015 was 2.343 (Jun. 2014 ) + 1.326 (Sep. 2014 ) + 1.237 (Dec. 2014 ) + 0.927 (Mar. 2015 ) = \$5.83 Mil.

Gross Profit is the numerator in the calculation of Gross Margin:

Synageva BioPharma Corp's Gross Margin for the quarter that ended in Mar. 2015 is calculated as

 Gross Margin (Q: Mar. 2015 ) = Gross Profit (Q: Mar. 2015 ) / Revenue (Q: Mar. 2015 ) = (Revenue - Cost of Goods Sold) / Revenue = 0.93 / 0.927 = 100.00 %

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.

Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Synageva BioPharma Corp had a gross margin of 100.00% for the quarter that ended in Mar. 2015 => Durable competitive advantage

Related Terms

Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Synageva BioPharma Corp Annual Data

 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Gross_Profit 10.51 15.24 49.39 19.65 15.18 0.60 2.10 14.95 13.37 6.49

Synageva BioPharma Corp Quarterly Data

 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Gross_Profit 4.88 5.12 3.41 1.37 3.47 1.59 2.34 1.33 1.24 0.93
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to \$400 per referral. ( Learn More)